Global health and equity in access to genomics and clinical trials with novel therapies
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-03-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X18300950 |
id |
doaj-6199bec46e034e2a889e82ceea6aeb4a |
---|---|
record_format |
Article |
spelling |
doaj-6199bec46e034e2a889e82ceea6aeb4a2020-11-25T02:02:57ZengElsevierThe Lancet Global Health2214-109X2018-03-016S25Global health and equity in access to genomics and clinical trials with novel therapiesAmit Oza0Princess Margaret Cancer Centre, Toronto, ON, Canadahttp://www.sciencedirect.com/science/article/pii/S2214109X18300950 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Amit Oza |
spellingShingle |
Amit Oza Global health and equity in access to genomics and clinical trials with novel therapies The Lancet Global Health |
author_facet |
Amit Oza |
author_sort |
Amit Oza |
title |
Global health and equity in access to genomics and clinical trials with novel therapies |
title_short |
Global health and equity in access to genomics and clinical trials with novel therapies |
title_full |
Global health and equity in access to genomics and clinical trials with novel therapies |
title_fullStr |
Global health and equity in access to genomics and clinical trials with novel therapies |
title_full_unstemmed |
Global health and equity in access to genomics and clinical trials with novel therapies |
title_sort |
global health and equity in access to genomics and clinical trials with novel therapies |
publisher |
Elsevier |
series |
The Lancet Global Health |
issn |
2214-109X |
publishDate |
2018-03-01 |
url |
http://www.sciencedirect.com/science/article/pii/S2214109X18300950 |
work_keys_str_mv |
AT amitoza globalhealthandequityinaccesstogenomicsandclinicaltrialswithnoveltherapies |
_version_ |
1724950427937538048 |